What Analysts Are Saying About Stericycle Stock
In the last three months, 6 analysts have published ratings on Stericycle (NASDAQ:SRCL), offering a diverse range of…
Decoding 7 Analyst Evaluations For Align Tech
In the preceding three months, 7 analysts have released ratings for Align Tech (NASDAQ:ALGN), presenting a wide array…
Key Takeaways From nVent Electric Analyst Ratings
During the last three months, 8 analysts shared their evaluations of nVent Electric (NYSE:NVT), revealing diverse outlooks from…
Peering Into Teleflex’s Recent Short Interest
Teleflex’s (NYSE:TFX) short percent of float has risen 46.73% since its last report. The company recently reported that…
How Is The Market Feeling About Akamai Techs?
Akamai Techs’s (NYSE:AKAM) short percent of float has risen 6.08% since its last report. The company recently reported…
A Closer Look at 15 Analyst Recommendations For Bank of America
15 analysts have expressed a variety of opinions on Bank of America (NYSE:BAC) over the past quarter, offering…
How Is The Market Feeling About StoneCo?
StoneCo’s (NYSE:STNE) short percent of float has risen 3.48% since its last report. The company recently reported that…
Why SOBR Safe Stock Is Soaring
SOBR Safe shares are trading higher Tuesday after the company announced SOBRsure device purchases from two new customers.
United Airlines Hits Brakes On Hiring This Year Due To Boeing Woes: Report
United Airlines is scaling back hiring due to Boeing's aircraft delivery delays, despite strong earnings outlook.
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: